Search research articles
Contact Us
Filters
Showing results (851-860 of 943) with videos related to
Page
of 95
Sort By:
The Journal of Clinical Investigation
|
September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV
Márton Kolossváry, Irini Sereti, Markella V Zanni, et al.
JACC. Advances
|
September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV
Christopher deFilippi, Sara McCallum, Markella V Zanni, et al.
Neurology. Genetics
|
October 27, 2021
Expanding the Phenotypic Spectrum of GPI Anchoring Deficiency Due to Biallelic Variants in <i>GPAA1</i>
Alison M R Castle, Smrithi Salian, Haim Bassan, et al.
AIDS (London, England)
|
December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
Pamela S Douglas, Sara McCallum, Michael T Lu, et al.
British Journal of Haematology
|
February 3, 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi
Annalisa Arcari, Valentina Tabanelli, Francesco Merli, et al.
Open Forum Infectious Diseases
|
April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Leukemia
|
June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
C Tarella, M Zanni, M Di Nicola, et al.
The Lancet. HIV
|
May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Esteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial
Markella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort
Borek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
Page
of 95
Search research articles
Search
Showing results (851-860 of 943) with videos related to
Sort By:
Page
of 95
The Journal of Clinical Investigation
|
September 9, 2025
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV
Márton Kolossváry, Irini Sereti, Markella V Zanni, et al.
JACC. Advances
|
September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV
Christopher deFilippi, Sara McCallum, Markella V Zanni, et al.
Neurology. Genetics
|
October 27, 2021
Expanding the Phenotypic Spectrum of GPI Anchoring Deficiency Due to Biallelic Variants in <i>GPAA1</i>
Alison M R Castle, Smrithi Salian, Haim Bassan, et al.
AIDS (London, England)
|
December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
Pamela S Douglas, Sara McCallum, Michael T Lu, et al.
British Journal of Haematology
|
February 3, 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi
Annalisa Arcari, Valentina Tabanelli, Francesco Merli, et al.
Open Forum Infectious Diseases
|
April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Leukemia
|
June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
C Tarella, M Zanni, M Di Nicola, et al.
The Lancet. HIV
|
May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Esteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial
Markella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort
Borek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
Page
of 95